GLGunnar Larfors

Gunnar Larfors

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gunnar Larfors has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Sven Cnattingius

    Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    2 shared publications
  • Anders Ekbom

    Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Bengt Simonsson

    Authors' Affiliations: 1Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm; and 2Unit of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

    1 shared publication
  • Helene Hallböök

    Authors' Affiliations: 1Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm; and 2Unit of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

    1 shared publication
  • Martin Höglund

    Department of Medical Sciences, Uppsala University, Uppsala, Sweden

    1 shared publication
  • Mats Lambe

    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Open Access

    Parental Age, Family Size, and Offspring's Risk of Childhood and Adult Acute Leukemia

    by Gunnar Larfors, Helene Hallböök, Bengt Simonsson

    Background: An association between childhood acute leukemia and advanced parental age was observed more than 50 years ago, and the association has been repeated in several, but not all, subsequent studies. In contrast to the many studies addressing childhood leukemia, few have included adult patients.


  • Pregnancy and risk of acute myeloid leukaemia - a case-control study

    by Gunnar Larfors, Martin Höglund, Sven Cnattingius

    Although maternal haematopoiesis is characterised by rapid proliferation and immunological adjustment, leukaemia seldom occurs in pregnant women. In this case-control study, we investigated pregnancy and risk of acute myeloid leukaemia (AML). A total of 785 women with AML diagnosed in ages 15-50 were compared with 1576 age- and sex-matched controls. At the time of diagnosis, 13 cases and 53 controls were pregnant (1.3% and 3.4%, respectively), resulting in a significantly reduced odds ratio of 0.44 (95% confidence interval 0.22-0.85). Odds ratios of AML during the years following childbirth were close to unity. The results suggest that pregnancy conveys a strong short-term protection against AML.


  • Placental Weight and Breast Cancer Survival in Young Women

    by Gunnar Larfors, Paul C. Lambert, Mats Lambe, Anders Ekbom, Sven Cnattingius

    A growing body of evidence indicates that reproductive history influences survival in breast cancer, especially among women diagnosed during or shortly after a pregnancy. However, little is known about the underlying mechanisms. We hypothesized that increasing placental weight, as an indirect marker of exposure to elevated hormone levels during pregnancy, would be associated with reduced survival in breast cancer. A cohort of 1873 women with at least one pregnancy after January 1st, 1973, and a subsequent breast cancer diagnosis before the end of 1991 were followed up for death or emigration through 2006. Information on placental weight and potential confounding factors were collected from medical records and from nationwide registers, which resulted in data on placental weight in the most recent pregnancy before diagnosis for 1,057 cases. For each 100-gram increase in placental weight, the adjusted hazard ratio of death was 1.09 [95% confidence interval (CI), 0.99-1.19]. The association was stronger among primiparous women (adjusted hazard ratio, 1.26; 95% CI, 1.09-1.47), and among women diagnosed during pregnancy or within 2 years from last birth (adjusted hazard ratio, 1.30; 95% CI, 1.06-1.59). Increasing placental weight is associated with reduced breast cancer survival. These findings are consistent with the hypothesis that the reduced survival in breast cancer among women with a recent childbirth is linked to pregnancy hormone exposure. (Cancer Epidemiol Biomarkers Prev 2009;18(3):777–83)